Skip to main content

Table 4 Basic information of HCV patients in different hypoxia-immune-based clusters

From: Exploration of a hypoxia-immune-related microenvironment gene signature and prediction model for hepatitis C-induced early-stage fibrosis

Characteristics

Whole cohort (216)

Hypoxia low Immune low (71)

Hypoxia high Immune high (30)

Survival

150 (69.44%)

58 (81.69%)

12 (40.00%)

Survival time (days)

3373.13 ± 1525.10

3551.83 ± 1352.96

2696.60 ± 1244.37

Bilirubin ≥ 1.0 mg/dl

108 (50.00%)

32 (45.07%)

17 (56.67%)

HCC

65 (30.09%)

18 (25.35%)

14 (46.67%)

  1. HCC Hepatic carcinoma, HCV hepatitis C virus